A study reports that liquid biopsy tests can detect early lung cancer recurrence months before imaging in NSCLC patients.
Quest Diagnostics and Waters will expand at-home HPV screening in 2027, offering extended genotyping via the Onclarity ...
A study finds permissive lab screening thresholds double primary aldosteronism detection rates versus Endocrine Society ...
Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...
Biodesix, in partnership with Bio-Rad and Thermo Fisher Scientific, advances tumor-informed and tumor-naïve MRD assays for ...
Gene by Gene will provide whole-genome sequencing for Children’s Mercy’s program, targeting nearly 100,000 pediatric genomes.
WHO grants Emergency Use Listing to BioFire’s Global Fever Special Pathogens Panel, enabling rapid detection of Ebola and 15 ...
Biodesix Partners With Vanderbilt to Develop Lung Cancer Risk Test Combining Blood Tests and Imaging
Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.
Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.
Diadem receives a US patent expanding protection for its AlzoSure Predict blood assay, which detects U-p53AZ, a biomarker ...
Revvity Signals Software launches Signals LabGistics, an AI-based platform designed to coordinate lab workflows and support GxP compliance across R&D and manufacturing.
A Penn State-led team developed a rapid syphilis test that detects low antibody titers in one step, with up to 46% stronger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results